Cytokinetics
CYTK | NASDAQ
$62.63
-$0.36 (-0.57%)
Nov 2, 2026, 2:31 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 255.27M | 129.84M | 122.52M | 225.47M | 74.94M | 73.68M | 94.86M | 46.89M | 190.52M | 119.98M | 113.4M | 99.69M | 68.64M | 101.62M | 65.58M | 106.24M | 93.63M | 115.42M | 112.67M | 90.56M | 37.15M | 44.59M |
Short-Term Investments | 910.42M | 688.71M | 759.7M | 737.07M | 783.2M | 864.54M | 981.16M | 964.8M | 866.63M | 498.99M | 501.8M | 439.55M | 497.08M | 562.35M | 717M | 761.43M | 492.4M | 493.55M | 358.97M | 387.07M | 313.15M | 380.98M |
Long-Term Investments | 538.32M | 254.72M | 335.05M | 288.82M | 178.2M | 150.69M | 145.06M | 269.17M | 305.36M | 15.38M | 40.53M | 15.47M | 26.87M | 40.41M | 46.71M | 28.54M | 10.67M | 77.08M | 152.05M | 191.3M | 73.67M | 34.66M |
Other Long-Term Assets | 25.94M | 22.31M | 17.34M | 16.81M | 14.55M | 12.7M | 7.71M | 7.73M | 7.68M | 7.81M | 8M | 8.19M | 8.34M | 8.12M | 9.69M | 7.76M | 8.05M | 7.26M | 7.19M | 6.68M | 6.45M | 6.4M |
Receivables | 24.43M | 6.83M | 17.76M | 1.81M | 8.41M | 2.01M | 16.65M | 244K | n/a | 834K | 1.28M | 2.5M | 985K | 1.01M | 147K | 2.29M | 1.97M | 6.06M | 51.82M | 644K | 2.7M | 4.51M |
Inventory | 380K | 154K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 13.93M | 16.99M | 13.01M | n/a | n/a | 15.28M | n/a | -375K | 18.91M | -375K | 19.68M | 19.87M | 15.66M | 12.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 1.21B | 839.47M | 916.98M | 977.35M | 886.54M | 956.05M | 1.11B | 1.02B | 1.07B | 638.7M | 628.05M | 561.42M | 586.58M | 680.63M | 795.19M | 884.28M | 602.25M | 623.53M | 535.67M | 494.94M | 364.23M | 433.12M |
Property-Plant & Equipment | 151.81M | 156.98M | 155.17M | 153.58M | 146.34M | 144.61M | 140.97M | 140.57M | 142.94M | 146.19M | 147.74M | 155.54M | 158.11M | 160.66M | 163.19M | 155.38M | 150.75M | 148.39M | 146.41M | 134.62M | 119.95M | 102.89M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 716.06M | 434.01M | 507.56M | 459.21M | 339.09M | 308M | 293.73M | 417.46M | 455.98M | 169.38M | 196.27M | 179.2M | 193.32M | 209.19M | 219.59M | 191.69M | 169.47M | 232.73M | 305.65M | 332.6M | 200.07M | 143.95M |
Total Assets | 1.92B | 1.27B | 1.42B | 1.44B | 1.23B | 1.26B | 1.4B | 1.44B | 1.52B | 808.08M | 824.32M | 740.61M | 779.9M | 889.82M | 1.01B | 1.08B | 771.72M | 856.25M | 841.32M | 827.54M | 564.3M | 577.06M |
Account Payables | 20.51M | 24.71M | 22.34M | 22.08M | 16.23M | 13.94M | 20.37M | 11.58M | 9.47M | 12.97M | 21.51M | 13.8M | 12.56M | 17.36M | 25.61M | 14.43M | 14.08M | 19.84M | 21.09M | 16.22M | 14.93M | 7.77M |
Deferred Revenue | 1.65M | 1.65M | 1.61M | 1.61M | 1.34M | 52.37M | 52.37M | n/a | -38.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 27.36M | 44.81M | 41.18M | 17.28M | 14.4M | 12.96M | 11.52M | 11.52M | 11.52M | 11.52M | 10.08M | n/a | n/a | n/a | 958K | n/a | n/a | n/a | n/a | 16.88M | 11.25M | 5.63M |
Other Current Liabilities | 34M | 65.55M | 80.08M | 52.09M | 55.8M | 36.13M | 56.25M | 45.91M | 81.79M | 22.18M | 39.81M | 36.09M | 22.5M | 21.62M | 22.89M | 23.56M | 14.28M | 12.87M | 16.47M | 14.16M | 9.78M | 9.43M |
Total Current Liabilities | 181.43M | 199.19M | 202.45M | 142.14M | 131.06M | 159.73M | 179.67M | 109.81M | 102.78M | 88.86M | 102.68M | 77.72M | 65.62M | 75.22M | 84.62M | 76.5M | 66.84M | 66.85M | 71.86M | 80.87M | 61.77M | 35.93M |
Long-Term Debt | 1.12B | 1.12B | 1.12B | 1.05B | 713.05M | 645.17M | 645.6M | 644.5M | 643.43M | 606.61M | 607.37M | 609.02M | 609.78M | 610.62M | 609.62M | 608.53M | 197.02M | 195.68M | 142.84M | 124.09M | 127.89M | 131.76M |
Other Long-Term Liabilities | 694.45M | 677.91M | 657.76M | 656.61M | 639.22M | 612.22M | 599.19M | 580.91M | 552.31M | 390.22M | 380.16M | 370.46M | 313.79M | 307.65M | 301.55M | 292.51M | 283.71M | 278.45M | 183.53M | 174.78M | 171.79M | 168.89M |
Total Long-Term Liabilities | 1.92B | 1.9B | 1.88B | 1.82B | 1.46B | 1.37B | 1.36B | 1.34B | 1.31B | 1.12B | 1.11B | 1.1B | 1.05B | 1.04B | 1.04B | 1.02B | 593.46M | 673.15M | 525.6M | 497.65M | 486.05M | 473.29M |
Total Liabilities | 2.1B | 2.1B | 2.08B | 1.96B | 1.59B | 1.53B | 1.54B | 1.45B | 1.42B | 1.2B | 1.21B | 1.18B | 1.11B | 1.12B | 1.12B | 1.09B | 660.3M | 739.99M | 597.46M | 578.52M | 547.81M | 509.22M |
Total Debt | 1.27B | 1.29B | 1.28B | 1.2B | 858.06M | 791.06M | 788.68M | 789.63M | 790.18M | 754.92M | 755.77M | 748.47M | 749.31M | 750.23M | 750.3M | 738.99M | 324.05M | 322.19M | 269.93M | 266.34M | 250.7M | 228.32M |
Book Value | -173.49M | -826.57M | -659.63M | -521.12M | -368.72M | -266.41M | -135.37M | -13.91M | 108.55M | -396.16M | -386.32M | -438.8M | -333.12M | -229.02M | -107.9M | -15.98M | 111.41M | 116.26M | 243.86M | 249.02M | 16.49M | 67.85M |
Book Value Per Share | -1.31 | -6.71 | -5.39 | -4.34 | -3.09 | -2.25 | -1.15 | -0.12 | 0.99 | -3.89 | -3.90 | -4.57 | -3.48 | -2.41 | -1.14 | -0.17 | 1.30 | 1.37 | 2.90 | 3.10 | 0.23 | 0.95 |
Common Stock | 138K | 124K | 123K | 122K | 119K | 119K | 118K | 118K | 117K | 105K | 102K | 94K | 94K | 94K | 94K | 93K | 85K | 85K | 84K | 84K | 72K | 71K |
Retained Earnings | -3.89B | -3.69B | -3.49B | -3.3B | -3B | -2.86B | -2.7B | -2.55B | -2.39B | -2.25B | -2.11B | -1.98B | -1.85B | -1.72B | -1.59B | -1.45B | -1.31B | -1.29B | -1.21B | -1.18B | -1.1B | -1.04B |
Comprehensive Income | -3.83M | -1.61M | 630K | 34K | -158K | 1.55M | 2.4M | 5.39M | -1.02M | -539K | -10K | -874K | -1.46M | -1.65M | -3.59M | -5.56M | -4.49M | -3.59M | -869K | -65K | -22K | 50K |
Shareholders Equity | -173.49M | -826.57M | -659.63M | -521.12M | -368.72M | -266.41M | -135.37M | -13.91M | 108.55M | -396.16M | -386.32M | -438.8M | -333.12M | -229.02M | -107.9M | -15.98M | 111.41M | 116.26M | 243.86M | 249.02M | 16.49M | 67.85M |
Total Investments | 1.45B | 943.43M | 1.09B | 1.03B | 961.4M | 1.02B | 1.13B | 1.23B | 1.17B | 514.36M | 542.33M | 455.02M | 523.95M | 602.75M | 763.7M | 789.97M | 503.06M | 570.64M | 511.02M | 578.37M | 386.82M | 415.65M |
Add to Watchlist
Select watchlists to add or remove CYTK